A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia
Clinical trial NCT06624020 · COMPLETED
Trial details
- NCT number
- NCT06624020
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-20
- Primary completion
- 2024-07-31
- Enrollment
- 1128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.